Research programme: LPAAT-beta inhibitors - Cell Therapeutics

Drug Profile

Research programme: LPAAT-beta inhibitors - Cell Therapeutics

Alternative Names: CT-32228; LPAAT-B inhibitors research programme - Cell Therapeutics; LPAAT-beta inhibitors research programme - Cell Therapeutics

Latest Information Update: 01 Sep 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cell Therapeutics
  • Class Small molecules
  • Mechanism of Action Lysophosphatidic acid acyltransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 01 Sep 2005 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 01 Jul 2005 A preclinical study has been added to the cancer pharmacodynamics section
  • 16 Apr 2004 This programme is still in active development - (95th Annual Meeting of the American Association for Cancer Research [AACR-2004])
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top